Absci Corporation ( ABSI) - Key Metrics
ABSI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.21 | -$0.18 | -$0.18 |
| 2026Q1 | $0 | -$0.19 | -$0.17 | -$0.17 |
| 2025Q4 | $0 | -$0.20 | -$0.19 | -$0.19 |
| 2025Q3 | $0 | -$0.20 | -$0.17 | -$0.18 |
| 2025Q2 | $0 | -$0.24 | -$0.13 | -$0.13 |
ABSI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -13.80 |
| 2026Q1 | 0% | -3.95 |
| 2025Q4 | 0% | -4.36 |
| 2025Q3 | 0% | -3.80 |
| 2025Q2 | 0% | -2.68 |
ABSI
Price: $9.49
52 week price:
Earnings Per Share: -0.79 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 382100
Market Capitalization: 1.5 billion